Beet Juice Supplementation for Coronary Artery Disease
Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications. However, it does require that participants have stable coronary artery disease on optimal medical therapy, which suggests you may need to continue your current treatment.
Research shows that beetroot juice, which is high in nitrates, can improve cardiovascular function by increasing nitric oxide levels in the body. This has been linked to better exercise performance and lower blood pressure, which may benefit people with coronary artery disease.
12345Research shows that beet juice supplementation, which is rich in nitrates, is generally safe for humans. It has been used in studies with older adults and patients with COPD (a lung condition) without significant safety concerns, and it can help lower blood pressure and improve exercise performance.
12678Beetroot juice supplementation is unique because it is rich in nitrates, which the body converts into nitric oxide, a molecule that helps improve blood flow and reduce blood pressure. This natural approach differs from standard medications by using dietary means to enhance cardiovascular health.
12579Eligibility Criteria
This trial is for adults aged 60-85 with stable coronary artery disease (CAD), confirmed by an angiogram or history of heart issues, who are on optimal medical therapy. Participants must be non-smokers, not engaged in regular aerobic exercise, and women should be postmenopausal. Those with recent heart attacks, strokes, severe lung disease, uncontrolled high blood pressure or certain infections like hepatitis B/C and HIV cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive beet juice supplementation to assess its effect on vascular and inspiratory muscle function
Follow-up
Participants are monitored for safety and effectiveness after treatment